News about patent registration has already become a regular occurrence.
Today we would like to announce that the technology of glucose measurement using sensors with organosilicon base (matrix) has been tested and prepared.
This technology is innovative. The results of testing this formula fully comply with the range of required measurements.
The results of the development are tested on real human blood obtained from the test group following the methodology.
The coating obtained by means of this technology is an additional, improved version of the membranes registered by our company.
Different versions of technologies are necessary for comparative analysis and selection of necessary characteristics for group tests.
Link to the notice of acceptance for the new application from the patent office dated 27.04.2024:
This is the third set of documents for our technologies filed in two months to the patent office from our InnoBioSystems engineering centre.
All holders of MLC shares are co-owners of these technologies and are entitled to receive income from their application around the world.
